Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
基本信息
- 批准号:10152509
- 负责人:
- 金额:$ 50.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-15 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAddressAdmission activityAdultAgeAlgorithmsAlzheimer&aposs disease related dementiaCaregiversCaringCharacteristicsClinicalClinical effectivenessCodeComparative Effectiveness ResearchComplicationCoronary heart diseaseCritical CareCustomDataData SetDementiaDevelopmentDiabetes MellitusDiagnosisDurable Medical EquipmentEffectivenessElderlyEmergency CareEmergency SituationEmergency treatmentEnrollmentEnsureEthicsEvaluationFutureHIVHealth PolicyHealth PrioritiesHealth systemHeart failureHeterogeneityHospitalizationHospitalsIndividualInferiorInstitute of Medicine (U.S.)InterventionKnowledgeLinkLiteratureMalignant NeoplasmsMeasuresMedicareMethodsModelingNatureObservational StudyOperative Surgical ProceduresOutcomePatient CarePatient-Focused OutcomesPatientsPatternPerformancePolicy MakerPopulationPrevalenceProceduresProcessProviderRaceRandomizedRandomized Controlled TrialsRecurrenceReportingResearch DesignRiskSeverity of illnessStrokeStructureSubgroupSurgeonSystemTechnologyTraumaTrauma patientTreatment CostTreatment outcomeUnited StatesUrsidae FamilyVariantVulnerable PopulationsWorkadverse outcomeage effectbasebeneficiarycare burdencare seekingcare systemscomorbiditycomparative effectivenesscomparative effectiveness analysiscomparative effectiveness studycontrol trialcostdesigndisorder riskemergency settingshigh riskhospital performanceinpatient serviceinsightinstrumentinterestlifetime riskminimally invasivemortalitynovelolder patientoperationoptimal treatmentspatient subsetspreferenceprovider factorsreadmission ratesresponseservice providerssociodemographic factorssurgery outcometreatment effecttreatment guidelines
项目摘要
Emergency general surgery (EGS) conditions are defined by a group of acute, non-trauma diagnoses that require
presentation to an emergency department for operative or non-operative care. In the US, 3-4 million adults are
hospitalized and treated for an EGS condition each year such that EGS conditions are responsible for 7% of all
hospitalizations. EGS conditions result in an estimated 800,000 operations annually and cost ≈ $28 billion. The
burden of EGS on inpatient care is greater than that of a new diagnosis of diabetes or cancer, coronary heart
disease, heart failure, stroke, or HIV. Older adults, who are at increased risk of adverse outcomes, comprise
more than half of the adult EGS population. Operative management of EGS conditions results in an overall
complication rate of 50%, with a readmission rate of 4-18%, and a mortality rate that can approach 15%, with
older patients demonstrating a significantly higher risk. Non-operative management is considered a reasonable
alternative yet studies show mixed results. Randomized control trials are limited by the invasive nature of
operative treatment, the heterogeneity of conditions, and the acute nature of EGS. Furthermore, most trials have
compared different types of operative or non-operative interventions, with relatively few comparing operative
treatment to non-operative treatment. A lack of evidence on the comparative effectiveness of operative and non-
operative treatment has been shown to result in unnecessary variations in treatment and inferior operative
outcomes. Furthermore, given the growing interest in the development of a regionalized system of care for EGS
patients since the Institute of Medicine Committee report on the Future of Emergency Care in the United States
Health System, knowledge on hospital performance in EGS is needed. This proposal aims to address these
gaps in the literature with the following specific aims: (1) To identify hospital-level factors associated with rankings
in EGS performance, (2) To evaluate the comparative effectiveness of operative and non-operative treatment in
specific EGS conditions and (3) To evaluate heterogeneity in the effectiveness of operative treatment.
Conditional effects of age, dementia and race will be examined amongst others. Using nationwide data from
Medicare beneficiaries, the proposed study will be the first comparative effectiveness analysis of operative and
non-operative treatment in EGS. The proposal employs: (1) template matching to define hospital quality in EGS
(2) an instrumental variable approach with optimal near-far matching to overcome confounding by indication and,
(3) interaction models to examine the conditional relationship between treatment and outcomes by patient
factors. In so doing, the findings will provide insights into hospital factors necessary for optimal EGS outcomes
and the comparative effectiveness of OP of EGS conditions. Policy makers will have evidence to inform systems-
level restructuring to address the crisis in emergency care. Patients, caregivers and providers will benefit from
the resultant high value care.
紧急通用手术(例如)疾病由一组急性的非创伤诊断来定义
向急诊科进行操作或非手术护理。在美国,3-4万成年人是
每年住院并治疗EGS状况
住院。例如,估计每年进行80万行动,耗资约280亿美元。这
EGS对住院护理的负担大于糖尿病或癌症的新诊断冠心病的负担
疾病,心力衰竭,中风或艾滋病毒。老年人患有不良后果的风险增加,完成
超过一半的成年人人口。 EGS条件的手术管理会导致总体
并发症率为50%,再入院率为4-18%,死亡率可能接近15%,而死亡率为15%
老年患者表现出明显更高的风险。非手术管理被认为是合理的
替代性研究表明结果不同。随机对照试验受到侵入性的限制
手术治疗,条件的异质性以及EGS的急性性质。此外,大多数试验都有
比较了不同类型的操作或非手术干预措施,相对较少比较操作
治疗非手术治疗。缺乏有关操作和非相比有效性的证据
已显示手术治疗会导致治疗和操作较低的不必要变化
结果。此外,鉴于对EGS的区域化护理体系的开发越来越兴趣
患者自医学研究所委员会报告美国的未来急诊室报告
卫生系统,需要EGS医院表现的知识。该建议旨在解决这些问题
文献中的差距具有以下特定目的:(1)确定与排名相关的医院级别因素
在EGS性能中,(2)评估操作和非手术治疗的比较有效性
特定的EGS条件和(3)评估手术治疗有效性的异质性。
年龄,痴呆症和种族的有条件影响将在其他情况下进行检查。使用来自全国范围的数据
Medicare受益人,拟议的研究将是对操作和
EGS中的非手术治疗。提案员工:(1)模板匹配以定义EGS的医院质量
(2)一种具有最佳接近匹配的仪器变量方法,以克服指示和,
(3)检查患者治疗与结局之间有条件关系的相互作用模型
因素。在这样做的情况下,这些发现将为最佳EGS结果所必需的医院因素提供见解
EGS条件的OP的比较有效性。政策制定者将有证据通知系统 -
重组以解决紧急护理危机。患者,照顾者和提供者将从
最终的高价值护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rachel Kelz其他文献
Rachel Kelz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rachel Kelz', 18)}}的其他基金
Personalized Provider Selection to Reduce Surgical Disparities
个性化的医疗服务提供者选择以减少手术差异
- 批准号:
10624968 - 财政年份:2022
- 资助金额:
$ 50.29万 - 项目类别:
Personalized Provider Selection to Reduce Surgical Disparities
个性化的医疗服务提供者选择以减少手术差异
- 批准号:
10445916 - 财政年份:2022
- 资助金额:
$ 50.29万 - 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
- 批准号:
10402798 - 财政年份:2019
- 资助金额:
$ 50.29万 - 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
- 批准号:
10667738 - 财政年份:2019
- 资助金额:
$ 50.29万 - 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
- 批准号:
10370161 - 财政年份:2019
- 资助金额:
$ 50.29万 - 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
- 批准号:
10619027 - 财政年份:2019
- 资助金额:
$ 50.29万 - 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
- 批准号:
10828099 - 财政年份:2019
- 资助金额:
$ 50.29万 - 项目类别:
Using Patient Outcomes to Inform Surgical Education
利用患者结果为外科教育提供信息
- 批准号:
9118829 - 财政年份:2015
- 资助金额:
$ 50.29万 - 项目类别:
Using Patient Outcomes to Inform Surgical Education
利用患者结果为外科教育提供信息
- 批准号:
9308803 - 财政年份:2015
- 资助金额:
$ 50.29万 - 项目类别:
Using Patient Outcomes to Inform Surgical Education
利用患者结果为外科教育提供信息
- 批准号:
8985515 - 财政年份:2015
- 资助金额:
$ 50.29万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
A comparative evaluation of overdose prevention programs in New York City and Rhode Island
纽约市和罗德岛州药物过量预防计划的比较评估
- 批准号:
10629749 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
Mixed methods examination of warning signs within 24 hours of suicide attempt in hospitalized adults
住院成人自杀未遂 24 小时内警告信号的混合方法检查
- 批准号:
10710712 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
The Social-Medical Network: Using a Network Approach to Explore the Integration of Informal and Formal Care Networks of Older Adults
社会医疗网络:利用网络方法探索老年人非正式和正式护理网络的整合
- 批准号:
10724756 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
Feasibility of a care team-focused action plan to improve quality of care for children and adolescents with inflammatory bowel disease
以护理团队为重点的行动计划的可行性,以提高炎症性肠病儿童和青少年的护理质量
- 批准号:
10724900 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别:
Elucidating Non-Routine Events Arising from Interhospital Transfers
阐明院间转移引起的非常规事件
- 批准号:
10749448 - 财政年份:2023
- 资助金额:
$ 50.29万 - 项目类别: